MedTrace Logo

Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children

NCT06271096 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-02-23

No results posted yet for this study

Summary

IM-midazolam in acute seizures, whenever IV cannulation is not possible. It is easy to administer and can be used in prehospital settings as IV cannulation requires experience, especially in pediatric age group. Moreover, the transit time to the hospital can be prolonged in our areas which can delay the treatment if intravenous cannulation is considered. More studies are required to assess the feasibility of administering IM-midazolam in a prehospital setting to control acute seizures

Conditions

Interventions

DRUG

Intra muscular Midazolam

ROUTE OF ADMINISTRATION AND DRUG EFFICACY COMPARED

DRUG

Intravascular Diazepam

ROUTE OF ADMINISTRATION AND DRUG EFFICACY COMPARED

Sponsors & Collaborators

  • Arooj Khan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2022-11-01
Completion
2024-01-01

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06271096 on ClinicalTrials.gov